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The present article describes an L-amino acid oxidase from Bothrops atrox snake venom as with anti-
protozoal activities in Trypanosoma cruzi and in different species of Leishmania (Leishmania braziliensis,
Leishmania donovani and Leishmania major). Leishmanicidal effects were inhibited by catalase, suggesting
that they are mediated by H2O2 production. Leishmania spp. cause a spectrum of diseases, ranging from
self-healing ulcers to disseminated and often fatal infections, depending on the species involved and the
host’s immune response. BatroxLAAO also displays bactericidal activity against both Gram-positive and
Gram-negative bacteria. The apoptosis induced by BatroxLAAO on HL-60 cell lines and PBMC cells was
determined by morphological cell evaluation using a mix of ﬂuorescent dyes. As revealed by ﬂow
cytometry analysis, suppression of cell proliferation with BatroxLAAO was accompanied by the signiﬁ-
cant accumulation of cells in the G0/G1 phase boundary in HL-60 cells. BatroxLAAO at 25 mg/mL and
50 mg/mL blocked G0eG1 transition, resulting in G0/G1 phase cell cycle arrest, thereby delaying the
progression of cells through S and G2/M phase in HL-60 cells. This was shown by an accentuated
decrease in the proportion of cells in S phase, and the almost absence of G2/M phase cell population.
BatroxLAAO is an interesting enzyme that provides a better understanding of the ophidian envenomation
mechanism, and has biotechnological potential as a model for therapeutic agents.
 2011 Elsevier Masson SAS. Open access under the Elsevier OA license.1. Introduction
Snake venoms are complex mixtures of proteins such as phos-
pholipases A2, disintegrins, metalloproteases, serine proteases, L-
amino acid oxidases, peptides, lipids, nucleotides and other
substances [1,2]. L-amino acid oxidases (LAAOs) are widely
distributed in the venomous snake families Viperidae, Crotalidae
and Elapidae [3]. LAAOs have been isolated from sea animals,
mucus of the giant snail Achatina fulica Férussac [4], ink of the sea
hare Aplysia californica [5], bacteria, fungi and plants [6].ax: þ55 16 3602 4275.
lo Alves Paiva), suvilela@usp.
nder the Elsevier OA license.LAAOs are ﬂavoenzymes catalyzing the stereospeciﬁc oxidative
deamination of a wide range of L-amino acids, which generates the
corresponding a-keto acids, H2O2 and ammonia [1,2,7]. LAAOs are
amongst the most abundant proteins in ophidian, particularly in
hemorrhagic venoms [6,8] and are capable of inducing the
apoptosis of various cell types [9e12]. Recent studies showed that
LAAOs are multifunctional enzymes exhibiting the induction or
inhibition of platelet aggregation [13,14], stimulation of edema
formation [15,16], hemorrhage [17,18], antibacterial, antiviral and
leishmanicidal functions [19e22].
Apoptosis is a controlled and regulated form of cell death that
plays an important role in the development and maintenance of
higher organisms. It is deﬁned by several morphological and
biochemical hallmarks, like the exposure of phosphatidylserine to
the outer leaﬂet of the plasma membrane, nuclear condensation,
and chromatin cleavage into oligonucleosomal fragments [23].
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cell cycle. This refers to the growth and division of cells in
a continuous and repetitive way. In the cell cycle, there are several
points in order to check the genetic material at cell division, in
which several proteins are present to repair DNA damage [24]. The
DNA-repair regulation is usually dependent or determined by two
different factors: the type of DNA lesion that must be repaired and
the characteristics of the substrate associated with the cell cycle.
Apoptotic processes and cellular damage are mechanisms of
action of some toxins, and several studies show potential applica-
tions of such substances as models for the development of
chemotherapy and anticancer agents. This study will describe the
toxic effect of BatroxLAAO in Leishmania spp., Trypanosoma cruzi
and Gram-positive and Gram-negative bacteria. The cytotoxic
activity of PBMC normal cells and HL-60 cancer cells was evaluated
after treatment with BatroxLAAO. BatroxLAAO can provide impor-
tant data for development of therapeutic strategies for more tar-
geted action, such as chemotherapy and anticancer agent
effectiveness.
2. Material and methods
2.1. Snake venom and reagents
The venom from Bothrops atrox was obtained from the Ser-
pentarium SANMARU (São Paulo, Brazil) and Institute Butantã (São
Paulo, Brazil). All chemicals used were of analytical grade.
2.2. Puriﬁcation of L-amino acid oxidase from B. atrox snake venom
The puriﬁcation of BatroxLAAO is in accordance to Alves et al.
(2008).
2.3. Bactericidal activity
The MIC values (the lowest concentration of the compound
capable of inhibiting microorganism growth) of BatroxLAAO were
determined in triplicate using the micro dilution broth method
(NCCLS e 2001) [25] in 96-well microplates. Standard strains from
the American Type Culture Collection of the following microor-
ganisms were used: Streptococcus mutans (ATCC 25175), Entero-
coccus faecalis (ATCC 4082), Sthaphylococcus aureus (ATCC 29213),
Pseudomonas aeruginosa (ATCC 27853) and Escherichia coli (ATCC
14948). The samples were dissolved in saline (0.85%) to a concen-
tration of 1 mg/mL, followed by dilution in tryptic soy broth to
achieve concentrations ranging from 4 to 80 mg/mL. The ﬁnal DMSO
content was 4% (v/v), and this solution was used as negative
control. The inoculumwas adjusted for each organism to yield a cell
concentration of 5106 CFU/mL (colony forming unitse CFU). One
inoculated well was included as a control of the adequacy of the
broth for organism growth. One non-inoculated well, free of anti-
microbial agent, was also included to ensure medium sterility.
Chlorhexidine dihydrochloride, streptomycin and penicillin were
used as positive controls. The microplates (96 wells) were sealed
with plastic ﬁlm and incubated at 37 C for 24 h. Next, an aqueous
solution of resazurin (30 mL of 0.02%) was added to the micro plates
to indicate microorganism viability. This procedure was based on
the methodology described by Palomino et al. [26].
The special ability of LAAO to induce bactericidal activity against
E. coli (ATCC 14948) and S. aureus (ATCC 29213) was also assayed by
agar diffusion. The colonies were incubated with 24 and 48 mg of
puriﬁed enzyme for 30 min and 60 min. The assay was carried out
at the Laboratory of Pharmaceutical Biotechnology, Universidade
Estadual Paulista (UNESP) according to the agar diffusion methoddescribed by Balows et al. [27], Soares et al. [28] and Stabeli et al.
[15].
2.4. Trypanocidal activity
BatroxLAAO (0.5e32 mM) was tested in vitro against T. cruzi
strain Y. Biological activity was evaluated by using the MTT color-
imetric method [MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide e SIGMA] in a micro plate reader at
570 nm, as described by Muelas-Serrano, Nogal-Ruiz and Gómez-
Barrio [29]. The negative control group containing solvent and
medium, the negative control group containing medium, and
groups containing the lignan compounds tested were all run in
parallel. All the assays were performed in triplicate.
2.5. Cytotoxic effect of LAAO on Leishmania species viability
The direct cytotoxic effect of the BatroxLAAO on Leishmania
species was measured. Brieﬂy, four species of the Leishmania genus
[1  106 promastigotes forms well1 of Leishmania braziliensis
(2904 P2), Leishmania major and Leishmania donovani (HU3 P6)]
were incubated separately in M199 medium supplemented with
10% heat inactivated fetal calf serum (FCS) in the presence or
absence of LAAO (0.5e32 mM) and catalase (0.5 mg/mL) for 24 h at
22 C in a micro plate assay. Control groups without LAAO and with
or without catalase were also tested. After the incubation time,
20 mL of the resazurin (SIGMA) solution (3 mM) was added and
incubated for 5 h at 37 C. The micro plates were read in a micro
plate reader (Sunrise-TECAN) at 570 nm. All assays were performed
in triplicate.
2.6. Cell culture
Human promyelocytic leukemia (HL-60) cells, obtained from
American Type Culture Collection (ATCC), were grown in RPMI-
1640, supplemented with 10% fetal calf serum and kept at 37 C in
a humidiﬁed atmosphere of 5% CO2 in air. PBMC (peripheral blood
mononuclear cell) cells were obtained from healthy individuals.
Human blood care procedure, guidelines and experimental proto-
cols were approved by Ethics Committee on Research (CEP) from
University of São Paulo, USP, Brazil (Protocol number:
0024.0.212.000-08).
2.7. Apoptotic and necrotic analysis by epiﬂuorescence microscopy
After the cells were exposed to BatroxLAAO, a morphological
evaluation was performed in order to discriminate between the
living cells and the necrotic or apoptotic ones. A solution with the
mixture of the non-permeant dye propidium iodide (PId5 mg/mL),
ﬂuorescein diacetate (FDAd15 mg/mL) and Hoechst 33342 (2 mg/
mL) was prepared in phosphate buffered salt solution and then
40 mL of the ﬂuorescent mix was added to the cells (2 mL ﬁnal
volume). After 5 min incubation at 37 C in 5% CO2 atmosphere, the
cell suspension was washed and re-suspended in 1 mL of the
medium [30]. Samples were dropped onto slides for observation
using a ﬂuorescent microscope (Olympus, Vanox AHBT3) with an
ultraviolet light ﬁlter.
2.8. Cell cycle analysis
Cells were treated with 5, 10, 25 and 50 mg/mL BatroxLAAO for
24 h. PBS buffer was used as negative control. Approximately
5  106 HL-60 cells were suspended for these experiments. Cells
were treated with RNase-A (50 U/mL) and labeled with PI (20 mg/
ml) for 3 h at room temperature. The percentage of cells in each
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a FACSCanto (Becton Dickison, Franklin Lakes, NJ, USA) and
analyzed using ModFit LT 2.0 1995-6 software (Verity Software
House Inc.)2.9. Statistical analysis
The statistical signiﬁcance of the experimental results was
determined by Student’s t-test. For all analysis, p < 0.05 was
accepted as a signiﬁcant probability level.Fig. 2. Bothrops atrox LAAO parasiticidal effects. Trypanocidal dose-dependent effect
induced by the BatroxLAAO enzyme on the Trypanosoma cruzi parasite. Statistical
signiﬁcance value means: *, **, ***(p < 0.05) when comparing all treatments.3. Results and discussion
SV-LAAOs (LAAOs from snake venom) have been objects of great
interest for pharmacological, molecular biology, and structural
studies. BatroxLAAO is an acidic glycoprotein with a pI w 4.4 and
Mr w 67,000 Da [12]. SV-LAAOs have been characterized showing
distinct molecular mass, substrate preference, pro/anti-apoptosis,
cytotoxicity, platelet aggregation, hemorrhage and edema as well
as bactericidal, leishmanicidal and anti-HIV activities
[6,11,13,19,22,31e35].3.1. Bactericidal activity
In this work BatroxLAAO exhibited bactericidal activity against
both Gram-positive and Gram-negative bacteria. BatroxLAAO (24
and 48 mg) displayed a bactericidal effect against E. coli and S.
aureus. In both doses (24 and 48 mg) of BatroxLAAO, after 30 min of
treatment, it did not present statistical difference (p > 0.05) in
bactericidal activity against E. coli and S. aureus (Fig. 1). After 60min
of treatment of BatroxLAAO (24 and 48 mg), it demonstrated
statistical difference (p < 0.05) compared to negative control E. coli
and S. aureus, respectively (Fig. 1). Chlorhexidine dihydrochloride,
streptomycin and penicillinwere used as positive controls (Table 1).
BatroxLAAO did not demonstrate efﬁcient activity as bactericidal
agent when compared to positives control.Fig. 1. This shows the bactericidal activity of the BatroxLAAO on the E. coli and S.
aureus. Different concentration values (24 and 48 mg) of BatroxLAAO were incubated
with 4  105 CFU for 30 min (p > 0.05 compared to non-treated group E. coli and S.
aureus, respectively) and 60 min (*p < 0.05 compared to a non-treated group of E. coli
and S. aureus, respectively). Each bar represents the mean  SD (n ¼ 3).
Table 1
Sensitivity of gram-positive and gram-negative bacteria to positive controls.
Escherichia coli 14948 Enterococcus faecalis 4082 Staphylococcu
Streptomycina 5.9 NT NT
Chlorhexidinea NT 3.688 NT
Penicillina NT NT 0.3688
aPositive control; Controls concentrations: 0.0115e5.9 mg/mL; NT: non-tested.3.2. Trypanocidal and Leishmanicidal activities
The cellular viability of T. cruzi and Leishmania sp. was investi-
gated after treatment with BatroxLAAO. The direct addition of
BatroxLAAO to trypomastigotes forms of T. cruzi (Fig. 2), as well as
to promastigotes of different Leishmania species resulted in a dose-
dependent parasite killing (Fig. 3). BatroxLAAO presented low
cytotoxicity effect in T. cruzi. BatroxLAAO (32 mM) showed
41.7  2.4% of parasites death. All concentrations tested demon-
strated signiﬁcant statistical value of (p < 0.05). We investigated
the cellular viability of L. braziliensis, L. donovani and L. major after
incubation with BatroxLAAO. This protein induced a dose-depen-
dent mortality of the promastigote forms. L. major, L. donovaniwere
most susceptible to the toxic effect of BatroxLAAO. After treatment
of BatroxLAAO (0.5, 2 and 8 mM), L. braziliensis demonstrated
statistical signiﬁcance (p < 0.001) when compared to L. donovani
and L. major.
Brieﬂy, the puriﬁed enzyme presented an EC50 of 23.34 mg/mL
against L. braziliensis, 4.3 mg/mL against L. donovani and 4.5 mg/mL
against L. major. Leishmania spp. had slightly different susceptibil-
ities to LAAOs from snake venom, especially for BatroxLAAO, as
observed from the EC50 of the puriﬁed enzyme. This could be
explained by different enzymatic patterns in each strain or species
[36]. Leishmania species were more sensitive to the action of this
LAAO than T. cruzi (EC50 ¼ 62.8 mg/mL). It is known that other
ophidian LAAOs exhibit parasiticidal activities as a result of
enzyme-catalyzed H2O2 production [19]. The toxic effect was
almost completely abolished by the addition of catalase, suggesting
that the release of H2O2 is directly involved with the parasiticidal
effect of the enzyme. The addition of 0.5 mg/mL of catalase effec-
tively abolished the effect of H2O2 produced by BatroxLAAO,
resulting in a level of high viability of the parasites (Fig. 3).
Recently, it was demonstrated that the Bothrops moojeni LAAO
caused a high mortality of promastigote forms of different speciess aureus 29213 Pseudomonas aeruginosa 27853 Streptococcus mutans 25175
>5.9 NT
NT 0.922
NT NT
Fig. 3. Bothrops atrox LAAO parasiticidal effects. Leishmanicidal dose-dependent effect
induced by BatroxLAAO enzymes on Leishmania spp. parasites. Statistical signiﬁcance
means: (p > 0.05). Leishmanicidal effect, after treatment with BatroxLAAO and catalase
was (0.5 mg/mL). Statistical signiﬁcance means *, ** (p < 0.001). Control wells were
cultured in the presence of culture medium alone and with 1% DMSO. Data are
expressed as the means  SD (n ¼ 3).
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against leishmaniasis and other intracellular parasitic infections
[37]. Ciscotto et al. [38] showed that crude venom from Bothrops
jararaca and HTP1 (LAAO puriﬁed from B. jararaca) exhibited
leishmanicidal activity against L. amazonensis. Upon incubation
with B. jararacawhole venom, 69% viability was obtained, whereas
47.5% viability was observed after incubationwith HTP1. In addition
of catalase abolished the leishmanicidal activity of both crude
venom and HTP1 [38].Fig. 4. The apoptotic and necrotic effects of the BatroxLAAO. The HL-60 cells were treated w
assessment of cell death by ﬂuorescence microscopy. (A) The arrow number 1 indicates nor
necrotic or apoptotic (PI); arrow number 3 indicates an apoptotic cell population with sp
magniﬁcation is shown here. Scale bar equals 25 mM. Details of procedures are described in
three independent experiments.BmarLAAO, an L-amino acid oxidase from Bothrops marajoensis
caused parasitic death in a dose-dependent manner on promasti-
gote forms of L. amazonensis and L. chagasi. The IC50 values were
approximately of 1 mg/mL [22].3.3. Cytotoxic activity
Venomous animals have evolved a vast array of toxins for prey
capture and defense. Toxins as L-amino acid oxidases have been
reported to show potent applications in pharmacology and cancer
therapy [6]. As the balance between therapeutic potential and toxic
side effects of a toxin is very important when evaluating its
usefulness as a pharmacological drug, experiments were designed
to investigate the in vitro cytotoxicity of BatroxLAAO against human
cancer cells (HL-60).
Many LAAOs demonstrate apoptosis-inducing activity
[12,19,23,39,40] and it is partially due to the generation of hydrogen
peroxide. Hydrogen peroxide belongs to reactive oxygen species
(ROS) and it is widely accepted that mitochondrial derangement
has been associated with the increased production of ROS [41,42].
Many researchers have reported that L-amino acid oxidases have
anti-proliferative effect on both leukemia and solid tumor
[6,12,19,23].
In this work BatroxLAAO conﬁrmed dose-dependent cytotox-
icity in HL-60 by ﬂuorescence microcopy as previously described
by Alves et al. [12]. The morphological analysis with three
different dyes (PI, DAF and Hoescht) in the HL-60 cell line is shown
on Fig. 4. This assay enables to detect apoptotic, necrotic and also
viable cells.
BatroxLAAO showed apoptotic and necrotic effects on HL-60
cells lines in a dose-dependent manner which was statistically
signiﬁcant compared to the negative control (p < 0.05) (Fig. 5A). At
50 mg/mL, BatroxLAAO was able to induce w42.8% of total cyto-
toxicity (Fig. 5A). BatroxLAAO (50 mg/mL) presented apoptotic effect
in 28.6  0.4% of HL-60 cancer cells (Fig. 5B) and, at the same
concentration, presented necrotic effect in 14.2  0.5% of HL-60
cancer cells (Fig. 5C). The viable cells after being treated with
BatroxLAAO (50 mg/mL) resulted in about 57.2  0.75%. This result
conﬁrmed the cytotoxicity potential of this protein (Fig. 5D).ith BatroxLAAO at a concentration 50 mg/mL for 24 h, and collected for morphological
mal living cells (Hoechst); (B) arrow number 2 indicates a dead cells population, either
otted nuclear bodies in blue (DAF). A representative ﬁgure from each group at 40
Materials and methods. Microphotographs were shown as representative results from
Fig. 5. Cytotoxicity effects in HL-60 cells lines. A) Apoptotic, necrotic and viable cells after exposure to BatroxLAAO (5, 25, 50 mg/mL); (for different letters p < 0.001, compared to
negative control; for the same letters p > 0.05, compared to NC); B) Apoptotic cells (for different letters p < 0.05, compared to NC); C) necrotic cells (for different letters p < 0.001,
compared to NC) and D) viable cells after treatment with BatroxLAAO (for different letters p < 0.001, compared to NC). NC ¼ negative control. PC ¼ positive control (camptothecin e
10 mM/mL). Values are expressed as  S.D. for three independent experiments, in which each measurement was performed in triplicate.
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cells (Fig. 6A). At 50 mg/mL, BatroxLAAO caused a cytotoxicity of
w35.32% (Fig. 6A). At 50 mg/mL of BatroxLAAO the apoptotic cells
were 18.16  0.44%, which was statistically signiﬁcant compared toFig. 6. Cytotoxicity effects in PBMC cells. A) Apoptotic and necrotic effects in PBMC cells after
negative control; for the same letters p > 0.05, compared to NC); B) Apoptotic cells (for diffe
compared to NC) and D) viable cells after treatment of BatroxLAAO (for different letters p <
10 mM/mL). Values are expressed as  S.D. for three independent experiments, in which eathe negative control (p < 0.05) (Fig. 6B). BatroxLAAO (50 mg/mL)
presented necrotic effect in 17.16  0.72% of PBMC cells (Fig. 6C).
The viable cells, after treatment with BatroxLAAO (50 mg/mL) made
about 64.66  0.92% PBMC (Fig. 6D). This protein (5 and 25 mg/mL)exposure to BatroxLAAO (5, 25, 50 mg/mL); (for different letters p < 0.001, compared to
rent letters p < 0.001, compared to NC), C) necrotic cells (for different letters p < 0.001,
0.001, compared to NC). NC ¼ negative control; PC ¼ positive control (camptothecin e
ch measurement was performed in triplicate.
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cells which was not statistically signiﬁcant compared to the nega-
tive control (p > 0.05) (Fig. 6B). Comparing to HL-60 cytotoxicity
BatroxLAAO presented low cytotoxicity in PBMC cells.
LAAO from Bungarus pirajai induced cytotoxic effects for S180
tumor cells, human breast (SKBR-3) cells, acute T cell leukemia
(Jurkat) cancer cells, and Erlich ascitic tumor (EAT) cells. No
signiﬁcant cell death was observed for macrophages [16]. ACTX-6,
an L-amino acid oxidase from A. acutus snake venom induced A549
cell death in vitro [39]. L-amino acid oxidase from Bungarus fasciatus
snake venom exhibited a cytotoxic effect on A549 cells and caused
up to 41.2% apoptosis of A549 cells following 12 h incubation period
[43]. LAAO from Vipera berus berus induced apoptosis in K562 cells
after 24 h of incubation [44].3.4. Cell cycle arrest
Emerging evidence has demonstrated that the anticancer
activity of certain chemotherapeutic agents is involved in inter-
ruption of the cell cycle, which is one of the preferred means of
managing cancer. In order to decipher the suppressive mechanisms
of BatroxLAAO onHL-60 cell lines, wemonitored the changes in cell
cycle distribution by cytometry ﬂow. Treatment with BatroxLAAO
resulted in a dose-dependent increase in the distribution of cells in
G0/G1 phase; with a decrease in S phase (Fig. 7). BatroxLAAO (5 and
10 mg/mL) showed 52.5% and 52.71% of cells in G0/G1 phase, 42.78%
and 44.56% in S phase, 4.72% and 2.71% of cells in G2/M phase,
respectively. BatroxLAAO (25 mg/mL) promoted 58.49% of cells in
G0/G1, 34.91% in S phase and 6.56% in G2/M phase. BatroxLAAO
(50 mg/mL) presented 68.12% of cells in G0/G1, conﬁrming the arrest
in this phase of cell cycle. The value of cells in G0/G1 after treatment
with BatroxLAAO (50 mg/mL) presents a statistically signiﬁcant
difference in value (p < 0.05) when compared with cells in S and
G2/M phases. The G1/S checkpoint prevents initiation of DNA
replication in cells that have damaged DNA. Cell cycle progression is
driven by phosphorylation events mediated by cyclin/cdk
complexes [45]. These cyclin/cdk complexes are the main targets of
the effectors of the G1/S checkpoint [45,46].
Studies by Zhang et al. [39] demonstrated that ACTX-6, an L-
amino acid oxidase from A. acutus induced markedly increased
accumulation of sub-G1 phase [39]. Bengalin, a protein from an
Indian black scorpion which is responsible for anti-proliferative
and apoptogenic activities against human leukemic cellsFig. 7. Inhibition of cell cycle progress in HL-60 cells by treatment with BatroxLAAO for
24 h. Cell cycle arrest in G0/G1 after treatment with BatroxLAAO (25 and 50 mg/mL).
Control: G0/G1 43.08%, S 53.3%, G2/M 3.61%. 5 mg/mL BatroxLAAO: G0/G1 52.5%, S
42.78%, G2/M 4.72%. 10 mg/mL BatroxLAAO: G0/G1 52.71%, S 44.56%, G2/M 2.71%. 25 mg/
mL BatroxLAAO: G0/G1 58.49%, S 34.91%, G2/M 6.56%. 50 mg/mL BatroxLAAO: G0/G1
68.12%, S 22.45%, G2/M 9.42%. Cells were ﬁxed with ethanol and stained with PI, and
then cell cycle distribution was analyzed by ﬂow cytometry. d,e p < 0.05 compared to
cells in G0/G1 after treatment with BatroxLAAO 25 mg/mL and 50 mg/mL, respectively.denominated U937 (histiocytic lymphoma) as well as the K562
(chronic myelogenous leukemia). Inhibition of U937 and K562 cell
proliferation occurred by apoptosis as evidenced from cell cycle
arrest at sub-G1 phase [47]. Unlike the cell cycle arrest in G1, other
compounds present apoptotic potential evidenced by arrest in G2.
A basic polypeptide from Naja naja atra venom (CTX-III) exerts its
speciﬁc anti-proliferative effects of solid tumor cells HepG2 via S
phase cell cycle arrest [48]. Ochratoxin A (OTA), a mycotoxin
commonly found in several food commodities worldwide could
induce GES-1 cells arrested in the G (2)/M phase [48].4. Conclusion
The present study will inﬂuence the future anticancer drug
development from snake venom and its mechanism of action. L-
amino acid oxidases could effectively trigger cell apoptosis in vitro.
Further studies will be necessary to be carried out to discover the
structure and the sites of activity of BatroxLAAO.Acknowledgements
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